Saturday, December 02, 2017 8:54:15 AM
I'm reluctant to post about the science involved because I am not a scientist and I am likely to garble what is in the PR without really adding anything insightful. I am more of a charts and fundamentals trader. As far as those are concerned, the chart looks pretty good lately and the fundamentals are non-existent, but the future looks better.
However, I have been reading the discussions of those who do understand the science, and they seem pretty excited.
In the nutshell: PH-10 is a Phase II therapy for psoriasis. This new data release is great in the sense that it shows that PH-10 was effective even in a 28-day trial (other trials are given 70 days) and even without the light therapy that was believed necessary to activate the drug. This was something nobody was expecting (some even were wondering if PH-10 had been abandoned).
The bad news is not very bad: PH-10 will probably need a new Level II trial for 70 days with light therapy so that the data can be compared with other drugs. This is bad because it will require more time and money, but it is good because the trials will be much cheaper than cancer-drug trials (i.e. PV-10) and shouldn't take very long to accomplish.
The potential for more financing has just become a lot stronger on the basis of this news. Even the potential for a buyout has gone from zero to "not completely zero", a step up. The company's plan all along has been to sell itself off to the highest bidder once it can generate revenue. To reach that point, we need news like we got this week.
So, I think the PH-10 news is bigger than our little .04 pps indicates. I think that this will start an uneven climb (lots of ups and downs) toward .05 this month. Which is a far cry from $3.50, and still leaves a lot of diehard shareholders deep underwater. On the other hand, .05 by January 1 represents a 500% pps increase in 2017, not too shabby.
As for PV-10 in February 2018, I really have no further information. Phase III was estimated to be done by then, but that was awhile ago and we have received no guidance on it. However, there was a PV-10 presentation this year, so they clearly are working on it.
As I said, I am no scientist as this post might illustrate. I am just interested in seeing the trials continue and data come in. While I have had impatient moments of angst this year, overall I am satisfied that the company is active and busy in completing what it started. The board has a financial stake in the company now, and a pps increase is their chief reward. So, they are motivated.
Recent PVCT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 09:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 01:54:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 03:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 07:06:10 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 11:23:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 11:19:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 05:21:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 07:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:06:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/23/2024 09:20:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 07:24:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 05:02:31 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/17/2024 08:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 07:50:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 01:30:18 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/20/2024 10:03:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:58:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 09:32:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 06:43:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 05:33:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 05:57:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/06/2024 05:56:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 02:22:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 08:16:08 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM